Honey bee neurogenomic responses to affiliative and agonistic social interactions

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/147835/1/gbb12509-sup-0003-FigureS3.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/147835/2/gbb12509-sup-0002-FigureS2.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/147835/3/gbb12509-sup-0001-FigureS1.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/147835/4/gbb12509.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/147835/5/gbb12509_am.pd

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate how disease burden changes with development. METHODS: We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) for all-cause mortality, cause-specific mortality, and non-fatal disease burden to derive HALE and DALYs by sex for 195 countries and territories from 1990 to 2015. We calculated DALYs by summing years of life lost (YLLs) and years of life lived with disability (YLDs) for each geography, age group, sex, and year. We estimated HALE using the Sullivan method, which draws from age-specific death rates and YLDs per capita. We then assessed how observed levels of DALYs and HALE differed from expected trends calculated with the Socio-demographic Index (SDI), a composite indicator constructed from measures of income per capita, average years of schooling, and total fertility rate. FINDINGS: Total global DALYs remained largely unchanged from 1990 to 2015, with decreases in communicable, neonatal, maternal, and nutritional (Group 1) disease DALYs offset by increased DALYs due to non-communicable diseases (NCDs). Much of this epidemiological transition was caused by changes in population growth and ageing, but it was accelerated by widespread improvements in SDI that also correlated strongly with the increasing importance of NCDs. Both total DALYs and age-standardised DALY rates due to most Group 1 causes significantly decreased by 2015, and although total burden climbed for the majority of NCDs, age-standardised DALY rates due to NCDs declined. Nonetheless, age-standardised DALY rates due to several high-burden NCDs (including osteoarthritis, drug use disorders, depression, diabetes, congenital birth defects, and skin, oral, and sense organ diseases) either increased or remained unchanged, leading to increases in their relative ranking in many geographies. From 2005 to 2015, HALE at birth increased by an average of 2·9 years (95% uncertainty interval 2·9-3·0) for men and 3·5 years (3·4-3·7) for women, while HALE at age 65 years improved by 0·85 years (0·78-0·92) and 1·2 years (1·1-1·3), respectively. Rising SDI was associated with consistently higher HALE and a somewhat smaller proportion of life spent with functional health loss; however, rising SDI was related to increases in total disability. Many countries and territories in central America and eastern sub-Saharan Africa had increasingly lower rates of disease burden than expected given their SDI. At the same time, a subset of geographies recorded a growing gap between observed and expected levels of DALYs, a trend driven mainly by rising burden due to war, interpersonal violence, and various NCDs. INTERPRETATION: Health is improving globally, but this means more populations are spending more time with functional health loss, an absolute expansion of morbidity. The proportion of life spent in ill health decreases somewhat with increasing SDI, a relative compression of morbidity, which supports continued efforts to elevate personal income, improve education, and limit fertility. Our analysis of DALYs and HALE and their relationship to SDI represents a robust framework on which to benchmark geography-specific health performance and SDG progress. Country-specific drivers of disease burden, particularly for causes with higher-than-expected DALYs, should inform financial and research investments, prevention efforts, health policies, and health system improvement initiatives for all countries along the development continuum. FUNDING: Bill & Melinda Gates Foundation

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015 : a systematic analysis for the Global Burden of Disease Study 2015

Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures. Methods We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing. We also expanded the database of vital registration, survey, and census data to 14 294 geography-year datapoints. For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality. We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes. We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies. First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility. Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality. Finally, we attributed changes in life expectancy to changes in cause of death. We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, life expectancy from birth increased from 61.7 years (95% uncertainty interval 61.4-61.9) in 1980 to 71.8 years (71.5-72.2) in 2015. Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence. From 2005 to 2015, male life expectancy in Syria dropped by 11.3 years (3.7-17.4), to 62.6 years (56.5-70.2). Total deaths increased by 4.1% (2.6-5.6) from 2005 to 2015, rising to 55.8 million (54.9 million to 56.6 million) in 2015, but age-standardised death rates fell by 17.0% (15.8-18.1) during this time, underscoring changes in population growth and shifts in global age structures. The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14.1% (12.6-16.0) to 39.8 million (39.2 million to 40.5 million) in 2015, whereas age-standardised rates decreased by 13.1% (11.9-14.3). Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias. By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42.1%, 39.1-44.6), malaria (43.1%, 34.7-51.8), neonatal preterm birth complications (29.8%, 24.8-34.9), and maternal disorders (29.1%, 19.3-37.1). Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders. Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East. In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146 000 deaths, 118 000-183 000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393 000 deaths, 228 000-532 000), although pathogen-specific mortality varied by region. Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause. Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI. Country patterns of premature mortality (measured as years of life lost [YLLs]) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory. Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI. Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death. Interpretation At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade. Progress has been faster in most countries than expected on the basis of development measured by the SDI. Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing. Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems. Copyright (C) The Author(s). Published by Elsevier Ltd.Peer reviewe

The Influence of Sleep on Negative Social Judgment

Sleep is crucial for emotional and physiological health by allowing for restorative processes to occur. Disruption of sleep, such as that caused by stress, can result in adverse health outcomes. Given the importance of stress levels and sleep for health, disparities present are troubling and have not been the focus of studies until recently. In mainly middle-age and older adult samples, ethnic minorities and those with lower socioeconomic status experience poorer sleep and higher stress. However, fewer studies with young adult samples exist. One form of stress these groups report higher incidences of is that caused by perceived judgment. Given sleep’s benefit on other forms of stress, the stress stemming from the feeling of being judged by others may also be reduced. My first two studies explore possible factors influencing sleep and stress. First, I examine whether the impact of stress on sleep is influenced by factors such as Ethnicity. Next, I explore whether environment, in the form of feelings of neighborhood safety, influences sleep and stress levels. My final study now looks at the beneficial effects of sleep with the hypothesis that sleep, through emotional regulation, can buffer the negative effects of being judged by a peer in a lab-setting

El Tlacuache Núm. 550 (2012). 550 Año 12 (2012) diciembre. El Tlacuache

Monte Albán, ayer y hoy por Martha Carmona Macías. -Aciertos de la visión intergal de la antropología y los pueblos originarios de México por Salomón Nahmad Sittón. -La tierra es de quien la trabaja: Reflexiones en torno al valor patrimonial de Monte Albán por Bernard Famhel Beyer. -La ética del restaurados frentea al reinterpretación del patrimonio por Frida Montes de Oca Fiol. -Los murciélagos en las culturas prehispánicas de Oaxaca por Laura Navarro, Joaquín Arroyo Cabrales.-Identificación del hueso trabajado de ballena (Monte Albán, Oaxaca) por Eduardo Corona Martínez, Martha Carmona Macías. -Los Mareños de Copalita, Huatulco, Humedales y Sociedad por Raúl Noé Matadamas Díaz

Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without Toxicity

In recent years, low doses of chemotherapy have been resumed and explored for the treatment of acute myeloid leukemia. Thus, CPX-351, a dual-drug liposomal encapsulation of cytarabine and daunorubicin, was approved by the US Food and Drug Administration, to deliver a synergistic 5 : 1 molar drug ratio into leukemia cells to a greater extent than normal bone marrow cells and significantly enhance survival compared with conventional treatment in older and newly diagnosed AML patients, but overall survival rate remains low; therefore, the need for new therapeutic options continues. Sodium caseinate (SC), a salt of casein, the main milk protein, has cytotoxic effect in leukemia cell lines, but promotes proliferation of hematopoietic normal cells, while its administration in leukemic mice promotes survival for more than 40 days, but bone marrow surviving mice still harbour leukemic cells, but it is not known whether the combination with cytarabine or daunorubicin can improve survival without damaging normal hematopoietic cells. Here, it is shown that, in vitro, the combination of the IC25 of SC-cytarabine or SC-daunorubicin synergizes in the elimination of leukemic cells, with evident induction of apoptosis, while the proliferation of mononuclear cells of bone marrow is not affected. In leukemic mice, the combined administration of SC-daunorubicin or SC-cytarabine promotes the highest survival rate at 40 days; in addition, no autoproliferating cells were detected in the bone marrow of survivors of more than 60 days, evidence of eradication of leukemic cells, but only the bone marrow of mice treated with the SC-daunorubicin combination proliferated in the presence of interleukin-3, which shows that this combination is not toxic to normal bone marrow cells, thus emerging as a possible antileukemic agent

Perilipin 2–positive mononuclear phagocytes accumulate in the diabetic retina and promote PPARγ-dependent vasodegeneration

International audienceType 2 diabetes mellitus (T2DM), characterized by hyperglycemia and dyslipidemia, leads to nonproliferative diabetic retinopathy (NPDR). NPDR is associated with blood-retina barrier disruption, plasma exudates, microvascular degeneration, elevated inflammatory cytokine levels, and monocyte (Mo) infiltration. Whether and how the diabetes-associated changes in plasma lipid and carbohydrate levels modify Mo differentiation remains unknown. Here, we show that mononuclear phagocytes (MPs) in areas of vascular leakage in DR donor retinas expressed perilipin 2 (PLIN2), a marker of intracellular lipid load. Strong upregulation of PLIN2 was also observed when healthy donor Mos were treated with plasma from patients with T2DM or with palmitate concentrations typical of those found in T2DM plasma, but not under high-glucose conditions. PLIN2 expression correlated with the expression of other key genes involved in lipid metabolism (ACADVL, PDK4) and the DR biomarkers ANGPTL4 and CXCL8. Mechanistically, we show that lipid-exposed MPs induced capillary degeneration in ex vivo explants that was inhibited by pharmaceutical inhibition of PPARγ signaling. Our study reveals a mechanism linking dyslipidemia-induced MP polarization to the increased inflammatory cytokine levels and microvascular degeneration that characterize NPDR. This study provides comprehensive insights into the glycemia-independent activation of Mos in T2DM and identifies MP PPARγ as a target for inhibition of lipid-activated MPs in DR

Medios de comunicación y derecho a la información en Jalisco, 2017

Un periodo de contrastes en materia de derecho a la información. Así fue 2017, año en que el diario El Informador festejó su centenario de existencia, en tanto que la revista Proceso Jalisco dejó de publicarse, tras más de un decenio de actividad. Se registró un aumento significativo de la oferta de los sitios periodísticos en línea, pero también una regresión en materia del derecho de las audiencias y una mayor presión de parte de diversos actores políticos sobre los medios de comunicación y los periodistas. En esta décima entrega del informe Medios de comunicación y derecho a la información en Jalisco, 2017, se examina el descenso en las condiciones laborales de los trabajadores de la información y de la propia labor periodística, así como el lento avance de los proyectos de radios comunitarias en la entidad. A la par, es materia de reflexión la manera en que los medios abordaron el sismo del 19 de septiembre y, en particular, el desplome del Colegio Rébsamen y la historia de “Frida Sofía”. Elaborado por estudiantes y profesores del ITESO, académicos de la Universidad de Guadalajara, representantes de organizaciones de la sociedad civil y profesionales del periodismo, este proyecto editorial refrenda su compromiso de documentar, analizar y reflexionar en torno al derecho a la información en Jalisco y México

Reporte Final PAP Primavera 2020: Playas región costa sur, Mezcala y UMAS, gestión integral de residuos del Estado de Jalisco, incorrecta disposición de los residuos líquidos denominados vinazas,CONAFOR y SEMADET

El proyecto de aplicación personal sobre el cual versa el presente reporte tiene con objetivo ser un vínculo de observancia de procuración de justicia ambiental, de tal forma, que, mediante este, se busca que los alumnos se conviertan en actores activos de las problemáticas ambientales que se gestan tanto en el nivel local, estatal y nacional. Para lograr esto, el equipo de alumnos se conforma por estudiantes de diversas carreras universitarias con la finalidad de generar un dialogo interseccional que permita generar el conocimiento y los insumos suficientes para generar estrategias y soluciones a problemas complejos, siempre buscando tener como eje rector la justicia ambiental. Para lograr el propósito de que los alumnos conozcan, desarrollen y propongan soluciones es que se genera un proceso de colaboración con una diversidad de actores relacionados dentro de la sociedad, de esta forma, buscando que el análisis crítico de la problemática ambiental que aborda al estado de Jalisco y las posibles soluciones para el apoyo de dichos grupos vulnerables. Este proyecto de aplicación profesional busca adentrar a los alumnos desde tres perspectivas distintas como lo son la academia, el sector privado y la administración pública buscando con esto dar a conocer el contexto de la complejidad del Derecho Ambiental a través de su aplicación desde una visión de procuración de justicia y la justiciabilidad. Dando como resultado una experiencia en donde el contacto con distintos sectores de la población, la aplicación de los conocimientos adquiridos durante la carrera y el análisis crítico de la realidad de los conflictos ambientales desde una perspectiva Ignaciana den como resultado la ejecución de mecanismos de procuración de justicia sobre la problemática ambiental que vive nuestro estado.ITESO, A.C